Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00408330
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2006-12-05
Brief Title:
A Study of Azelaic Acid AzA 15 Gel in the Treatment of Seborrheic Dermatitis of the Face
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Study Overview
Official Title:
A Double-Blind Randomized Vehicle-Controlled Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid AzA 15 Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face
Detailed Description:
To test the efficacy and safety of azelaic acid 15 gel in the treatment of seborrheic dermatitis of the face
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-002060-26 | EUDRACT_NUMBER | None | None |